Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Operating activities
Net increase (decrease) in net assets resulting from operations	$ 20,527,836	$ 4,918,304	$ 3,822,148
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net realized (gain) loss	(3,222)	0	1,580
Change in net unrealized (appreciation)/ depreciation of investments	1,095,138	7,134,450	(1,669,324)
Net amortization of investment discounts and premiums	(1,383,117)	(1,061,078)	(279,930)
Amortization of deferred debt issuance costs	196,300	310,284	167,718
Interest and dividend income paid in kind	(1,535,999)	(228,972)	(26,479)
Changes in assets and liabilities:
Purchases of investments	(71,857,910)	(115,975,758)	(116,870,974)
Proceeds from disposition of investments	33,242,394	13,227,195	4,270,573
Decrease (increase) in interest receivable	(1,186,671)	(1,047,440)	(807,950)
Increase (decrease) in incentive fees payable	919,929	(304,622)	304,622
Increase (decrease) in payable for investments purchased	878,825	(10,093,643)	8,383,118
Increase (decrease) in management fees payable	(445,634)	445,634	0
Decrease (increase) in prepaid expenses and other assets	153,805	(160,929)	(76,199)
Increase (decrease) in reimbursements due to the Advisor	(135,752)	142,503	31,824
Increase (decrease) in interest and debt related payables	(23,359)	39,751	73,441
Increase (decrease) in accrued capital gains incentive fees	0	(165,778)	165,778
Increase (decrease) in accrued expenses and other liabilities	87,938	191,421	193,928
Net cash provided by (used in) operating activities	(19,469,499)	(102,628,678)	(102,316,126)
Financing activities
Draws on credit facilities	41,500,000	107,500,000	50,000,000
Repayments of credit facility draws	(59,500,000)	(92,000,000)	(28,000,000)
Proceeds from shares of common stock sold	65,216,667	95,316,667	55,183,333
Payments of debt issuance costs	(100,000)	0	(618,638)
Payments of equity offering costs	0	0	(267,621)
Dividends paid to shareholders	(26,132,059)	(7,288,646)	(2,216,478)
Net cash provided by (used in) financing activities	20,984,608	103,528,021	74,080,596
Net increase (decrease) in cash and cash equivalents (including restricted cash)	1,515,109	899,343	(28,235,530)
Cash and cash equivalents (including restricted cash) at beginning of period	2,856,829	1,957,486	30,193,016
Cash and cash equivalents (including restricted cash) at end of period	4,371,938	2,856,829	1,957,486
Supplemental cash flow information
Interest payments	2,471,146	1,573,459	205,413
Excise tax payments	1,809	0	0
Dividends payable	$ 0	$ 4,350,000	$ 0